Suppr超能文献

喹吡罗和8-羟基二丙胺通过作用于强迫症神经回路的不同功能部分,诱导雄性大鼠出现强迫检查行为。

Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit.

作者信息

Alkhatib Ahmad H, Dvorkin-Gheva Anna, Szechtman Henry

机构信息

Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

Behav Pharmacol. 2013 Feb;24(1):65-73. doi: 10.1097/FBP.0b013e32835d5b7a.

Abstract

This study investigated whether the serotonin 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) can induce compulsive checking in a large open field, as does the dopamine D2/D3 receptor agonist quinpirole. To induce compulsive checking, male rats were exposed to eight injections of either 8-OH-DPAT (1 mg/kg), quinpirole (0.2 mg/kg), or saline. Subsequently, to assess cross-sensitization, rats received an acute challenge of 8-OH-DPAT or quinpirole. The results showed that treatment with 8-OH-DPAT induces compulsive checking and may have a stronger effect on this behavior compared with quinpirole. However, there was no cross-sensitization between 8-OH-DPAT and quinpirole on measures of compulsive checking and locomotion. Moreover, the spatial distribution of locomotor paths in 8-OH-DPAT animals was more confined and invariant than in quinpirole rats; their rate of locomotor sensitization was also faster than that in quinpirole animals. Thus, although 8-OH-DPAT and quinpirole can induce compulsive checking in a large open field, the results suggest that they do so differently. It is suggested that 8-OH-DPAT and quinpirole probably produce compulsive behavior by acting on different parts of a security motivation circuit underlying obsessive-compulsive disorder. Quinpirole may induce compulsive checking behavior by directly driving dopaminergic activity mediating the motivational drive to check. Conversely, 8-OH-DPAT may perpetuate the activated motivational state by inhibiting the serotonergic-negative feedback signals that normally deactivate the obsessive-compulsive disorder circuit.

摘要

本研究调查了血清素5-HT1A受体激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)是否能像多巴胺D2/D3受体激动剂喹吡罗一样,在大型开放场地诱导强迫性检查行为。为了诱导强迫性检查行为,对雄性大鼠进行八次注射,分别注射8-OH-DPAT(1毫克/千克)、喹吡罗(0.2毫克/千克)或生理盐水。随后,为了评估交叉致敏作用,给大鼠注射一次8-OH-DPAT或喹吡罗进行急性激发试验。结果表明,与喹吡罗相比,8-OH-DPAT治疗可诱导强迫性检查行为,且对该行为的影响可能更强。然而,在强迫性检查和运动能力的测量方面,8-OH-DPAT和喹吡罗之间没有交叉致敏作用。此外,8-OH-DPAT处理组动物运动路径的空间分布比喹吡罗处理组更局限且更稳定;其运动致敏率也比喹吡罗处理组动物更快。因此,尽管8-OH-DPAT和喹吡罗都能在大型开放场地诱导强迫性检查行为,但结果表明它们的作用方式不同。研究表明,8-OH-DPAT和喹吡罗可能通过作用于强迫症潜在的安全动机回路的不同部位来产生强迫行为。喹吡罗可能通过直接驱动介导检查动机的多巴胺能活动来诱导强迫性检查行为。相反,8-OH-DPAT可能通过抑制通常使强迫症回路失活的血清素负反馈信号,使激活的动机状态持续存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验